Network origin in Barrie Charles Finnin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Barrie Charles Finnin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GENETIC TECHNOLOGIES LIMITED | Miscellaneous Commercial Services | Director of Finance/CFO | |
| SAMSARA VISION, INC. | Medical Specialties | Director/Board Member | |
| NEUREN PHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Chairman Chief Executive Officer | |
iCeutica, Inc.
 iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Founder | |
Australia & New Zealand Banking Group Ltd. (Research Firm)
 Australia & New Zealand Banking Group Ltd. (Research Firm) Investment ManagersFinance Australia & New Zealand Banking Group Ltd. (Research Firm) (ANZ-Research) is the investment research division of Australia & New Zealand Banking Group Ltd., a multinational banking and financial services company headquartered in Melbourne, Australia. The firm was founded in 1835 and do-business-as ANZ Banking Group Ltd. ANZ-Research provides detailed analysis and forecasts on current and emerging economic trends, as well as financial and commodity markets. The firm’s regional economics teams provide macroeconomic analysis on Australia, New Zealand, Emerging Asia, Greater China and the G3 economies. While their strategists cover foreign exchange, rates and commodity markets. | Investment Managers | Corporate Officer/Principal | |
Layerbio, Inc.
 Layerbio, Inc. Miscellaneous Commercial ServicesCommercial Services Layerbio, Inc. develops bio erodible sustained-release technology for use in standard intraocular lens in cataract surgery. The private company is based in Lexington, MA. The company was founded in 2013 by Kenneth J. Mandell, Paula Hammond. Kenneth J. Mandell has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Bath | College/University | Undergraduate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| RESONANCE HEALTH LIMITED | Medical/Nursing Services | Chief Executive Officer | |
| University of Aberdeen | College/University | Undergraduate Degree | |
| BTC HEALTH LIMITED | Investment Managers | Chairman Director/Board Member | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Reading | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| University of Connecticut | College/University | Undergraduate Degree | |
| IMMURON LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Western Australia | College/University | Corporate Officer/Principal | |
| RMIT University | College/University | Masters Business Admin | |
| University of Cardiff | College/University | Doctorate Degree Doctorate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Perron Institute for Neurological & Translational Science Ltd. | Director/Board Member | ||
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Sales & Marketing | |
Yuuwa Capital Management Pty Ltd.
 Yuuwa Capital Management Pty Ltd. Investment ManagersFinance Yuuwa Capital Management Pty Ltd. ( Yuuwa Capital Management ) is a venture capital firm, founded in 2009 by Liddy McCall , James Williams, Matthew Macfarlane. The firm is headquartered in Bentley, Western Australia. | Investment Managers | Founder | |
| SIENNA CANCER DIAGNOSTICS LIMITED | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ADALTA LIMITED | Biotechnology | Director/Board Member | |
Fitgenes Australia Pty Ltd.
 Fitgenes Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fitgenes Ltd., Fitgenes Australia Pty Ltd. provides education on Nutrigenomics. The company is based in Brisbane, Australia. Fitgenes Australia was acquired by Fitgenes Ltd. | Miscellaneous Commercial Services | Director/Board Member | |
Sprout Pharmaceuticals, Inc.
 Sprout Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sprout Pharmaceuticals, Inc. provides delivery of a treatment option for the unmet need of women with Hypoactive Sexual Desire Disorder. The company was founded by Cynthia E. Whitehead and Robert S. Whitehead on November 29, 2011 and is headquartered in Raleigh, NC. | Pharmaceuticals: Major | President | |
| Argus Biomedical Pty Ltd. | Chief Executive Officer | ||
Nexgen Plants Pty Ltd.
 Nexgen Plants Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Nexgen Plants Pty Ltd. develops anti-viral technology solutions that enables virus resistant plant varieties to be developed for major food, fibre, energy and ornamental crops. The company was founded in 2013 and is headquartered in St. Lucia, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
Gordiantec Pty Ltd.
 Gordiantec Pty Ltd. Packaged SoftwareTechnology Services Gordiantec Pty Ltd. offers genetics research. The company is headquartered in Bentley, Australia. | Packaged Software | Director/Board Member | |
| Linear Clinical Research Ltd. | Director/Board Member Director/Board Member | ||
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
| Eridan Technology Pty Ltd. | Director/Board Member | ||
| Agventures Ltd. | Director/Board Member | ||
| Neuroendocrinz Ltd. | Director/Board Member | ||
| ICETANA LIMITED | Packaged Software | Director/Board Member Director/Board Member | |
Yuuwa Capital LP
 Yuuwa Capital LP Investment ManagersFinance Yuuwa Capital LP seeks investment opportunities in the companies located in Australia primarily in Perth. The fund focuses on companies operating in the fields of software, information & communications technology ventures, life sciences and biotech sectors. It provides financing for early & seed stage capital requirements with investment size ranges between $1 million to $5 million. | Investment Managers | Founder | |
| CANN GROUP LIMITED | Agricultural Commodities/Milling | Director of Finance/CFO | |
Certa Therapeutics Pty Ltd.
 Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
Australian Investment Council
 Australian Investment Council Miscellaneous Commercial ServicesCommercial Services Australian Investment Council is an Australian private company located in Sydney. The firm operates as an association. Navleen Prasad has been the CEO since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Visus Therapeutics, Inc.
 Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| Supertrans Medical Ltd. | Director/Board Member | ||
| TMV Associates LLC | Corporate Officer/Principal | ||
| Aleia Therapeutics Pty Ltd. | Director/Board Member | ||
| Demagtech Pty Ltd. | Director/Board Member |
Statistics
International
| Australia | 33 |
| United States | 10 |
| United Kingdom | 6 |
| New Zealand | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 87 |
| Corporate Officer/Principal | 39 |
| Chairman | 22 |
| Chief Executive Officer | 16 |
| Undergraduate Degree | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Chris Nave | 24 |
| Williams James | 22 |
| Ross Dobinson | 21 |
| Henry Kenneth Windle | 14 |
| Hugh Alsop | 13 |
| Tracy M. Valorie | 13 |
| James L. Foght | 13 |
| Richard Treagus | 10 |
| Tony di Pietro | 9 |
| Jon Pilcher | 7 |
| Nina Webster | 7 |
| Andrew Donohue | 5 |
| Russell John Tait | 5 |
| Andrew Humberstone | 4 |
| Igor Gonda | 4 |
- Stock Market
- Insiders
- Barrie Charles Finnin
- Company connections
